Black Hawk Acquisition CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Black Hawk Acquisition Corp. will merge with Vesicor Therapeutics, a biotechnology company focused on p53-based cancer therapeutics, valuing Vesicor at $70 million.
NASDAQ
Black Hawk Management LLC converted 1,725,000 Class B ordinary shares of Black Hawk Acquisition Corp into an equal number of Class A ordinary shares on April 4, 2024.